Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal CancerDigestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colorectal cancer, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorderRecruitingPhase 22026-09-01NCT06992258

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Criterium, Inc.5

13 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Inova Schar CancerFairfaxUnited States8
Mays Cancer Center at University of Texas Health at San AntonioSan AntonioUnited States1
Medical University of South Carolina / MUSCCharlestonUnited States1
Mount Sinai Cancer Research ProgramMiami BeachUnited States1
NYU Langone HealthNew YorkUnited States403
Orlando Health Cancer InstituteOrlandoUnited States97
Rutgers Cancer InstituteNew BrunswickUnited States6
Swedish Cancer InstituteSeattleUnited States67
Thomas Jefferson University - Sidney Kimmel Comprehensive Cancer CenterPhiladelphiaUnited States1
UPenn Lancaster-Ann B. Barshinger Cancer InstituteLancasterUnited States1
UPMC / University of Pittsburgh Medical CenterPittsburghUnited States1
Vanderbilt University Medical CenterNashvilleUnited States427
Yale UniversityNew HavenUnited States352